🔎 Trials Near Me

Home › Blood Cancers › Utah › Salt Lake City

Blood Cancers clinical trials in Salt Lake City, UT

8 studies for Blood Cancers are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecruitingPhase 2
  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • University of Utah, Salt Lake City
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

RecruitingObservational study
  • Primary Children's Hospital, Salt Lake City
Up to age 30 · All sexes · Updated Jun 18, 2026 · NCT06579469

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

RecruitingObservational study
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RecruitingPhase 1
  • University of Utah, Salt Lake City
Ages 13 and older · All sexes · Updated May 5, 2026 · NCT04771572

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

RecruitingPhase 3
  • Primary Children's Hospital, Salt Lake City
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RecruitingPhase 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Primary Children's Hospital, Salt Lake City
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

Blood Cancers trials in other cities

Other studies in Salt Lake City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.